Generics 8

Biosimilars

Medical devices

Nutraceuticals

Filters

Glycopyrronium bromide manufacturers

8 products found

Filters

8 products found

glycopyrronium bromide + indacaterol

Capsules 43μg + 85μg

Dossier type
EU CTD
Country of origin
European Union
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
Vietnam

Manufacturer #358

A pharmaceutical manufacturer based in the EU that is active in 70+ countries worldwide selling its products in the EU, Australia, Pacific region, and Asia for 30+ years. The company owns several manufacturing plants that comply with EU GMP requirements with production facilities for Rx products, OTC products, nutraceuticals, and medical devices. Its key therapy areas are diabetology, oncology, and neuropsychiatry. The company possesses several R&D centers with hundreds of patents and provides e-CTD format dossiers.

Manufacturer usually replies in 14 days

glycopyrronium bromide

Solution for injection 0,2mg/ml (1ml, 2ml)

Dossier type
EU CTD
Country of origin
India
Dossier status
Under Development
GMP approvals
EU GMP
Unavailable markets
New Zealand, Australia

Manufacturer #10627

Manufacturer usually replies in 7 days

glycopyrronium bromide

Ampoules, injection 200mcg/ml

Dossier type
CTD
Country of origin
India
Dossier status
Ready
GMP approvals
EU GMP

Manufacturer #15910

Manufacturer usually replies in 12 days

Want to view all 8 products? Create your free account today!

Glycopyrronium Bromide Manufacturers

Markets of interest

As an antispasmodic Glycopyrronium Bromide prescribed to treat some disorders of the gastrointestinal tract and to reduce salivation with some anesthetics. The substance is available for sale in the form of ampoules, solution for injection, capsules, from manufacturers in various countries including Y. The drug is provided by a wide range of Glycopyrronium Bromide suppliers from various countries including the Y, Y, and Y. Mostly due to the availability of raw materials for the manufacturing process and low labor costs, the leading Glycopyrronium Bromide manufacturers and distributors are based in China Bangladesh, and Turkey.

Licensing and brand names

In October 2015, Glycopyrronium Bromide was approved by the FDA for use as a standalone treatment for Chronic obstructive pulmonary disease (COPD) in the USA. The medication was approved by the EMA in the European Union in 2012. The medication is presently approved in many countries and is available in both generic and trade name versions. The medication is marketed under the trade names including Cuvposa, Enurev Breezhaler. One of the most popular branded versions of Glycopyrronium Bromide is manufactured and supplied by the Dutch pharmaceutical company Duchefa Farma B.V. Other manufacturing companies and distributors from India, Spain, Switzerland, Portugal, France, and Italy have also successfully adapted to the demands of the global marketplace and produce a variant of the drug with Glycopyrronium Bromide as an active ingredient.

Target supply price

The wholesale acquisition cost for Glycopyrronium Bromide injectable solution (0.2 mg/mL) is around $67 for a supply of 25 milliliters. The retail price of 85mcg + 43 mcg inhalable powder (hard capsules) N30 x 1 + 1 inhaler 46.45 € of the substance in Europe reaches EUR. The medication wholesale prices and commercial terms can vary depending on the supplier. The medication wholesale prices and commercial terms can vary depending on the supplier.

Information from manufacturers

We provide a detailed list of the Glycopyrronium Bromide manufacturers and suppliers that you are looking for. You can also find the dossier status of Glycopyrronium Bromide and the GMP approvals of the different variants of the medication. The product description of all Glycopyrronium Bromide suppliers contains essential information about the medication you order including clinical data, stability zones, and a list of countries where Glycopyrronium Bromide is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms as well as delivery terms. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified Follicle-stimulating hormone suppliers and distributors enter our online marketplace, offering you a risk-free global B2B pharmaceutical sales platform.